FormDSignal
37

Janus Henderson Biotech Innovation Fund II Access raises $155M as hedge fund with 610 investors

Fund raise update · Hedge fund · Open-ended · NEW YORK, NY · Form D/A filed 2026-10-13 · sponsor: Janus Henderson · all Janus Henderson Biotech vehicles

Janus Henderson Biotech Innovation Fund II Access LLC, a Delaware hedge fund, has raised $155.01M from 610 investors since September 2025. The fund operates under Regulation D exemptions 3(c)(7) for qualified purchasers and is administered by iCapital Alternative Investments LLC.

$100M+ sold3(c)(7) — qualified purchasersHedge fund

Why now — by persona

  • Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

- Asterion Fund Services, L.L.C.Manager of the Issuer
- Maples Fiduciary Services (Delaware) Inc.Managing Member of the Manager of the Issuer ("MFSD Inc.")
- iCapital Alternative Investments LLCAdministrator of the Issuer
Coleen GasiewskiExecutive Officer
Scott HuffExecutive Officer
Max SchwartzAuthorized Signatory of the Administrator of the Issuer

Signed by Max Schwartz, Authorized Signatory of the Administrator of the Issuer.

Placement agents / sales compensation: Merrill Lynch, Pierce, Fenner & Smith Incorporated

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer

All Janus Henderson Biotech vehicles on Form D →

More from Janus Henderson